Busulfan-Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: An exposed-unexposed study evaluating the clinical impact of the order of drug administration

M. E. Dourthe; N. Ternès; D. Gajda; A. Paci; C. Dufour; E. Benhamou; D. Valteau-Couanet

doi:10.1038/bmt.2016.109

Busulfan-Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: An exposed-unexposed study evaluating the clinical impact of the order of drug administration

M. E. Dourthe, N. Ternès, D. Gajda, A. Paci, C. Dufour, E. Benhamou, D. Valteau-Couanet

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

6 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	1265-1267
Nombre de pages	3
journal	Bone Marrow Transplantation
Volume	51
Numéro de publication	9
Les DOIs	https://doi.org/10.1038/bmt.2016.109
état	Publié - 1 sept. 2016

Accès au document

10.1038/bmt.2016.109

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Dourthe, M. E., Ternès, N., Gajda, D., Paci, A., Dufour, C., Benhamou, E., & Valteau-Couanet, D. (2016). Busulfan-Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: An exposed-unexposed study evaluating the clinical impact of the order of drug administration. Bone Marrow Transplantation, 51(9), 1265-1267. https://doi.org/10.1038/bmt.2016.109

@article{c1467cdeaff14468856932ec7a66be51,

title = "Busulfan-Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: An exposed-unexposed study evaluating the clinical impact of the order of drug administration",

author = "Dourthe, {M. E.} and N. Tern{\`e}s and D. Gajda and A. Paci and C. Dufour and E. Benhamou and D. Valteau-Couanet",

year = "2016",

month = sep,

day = "1",

doi = "10.1038/bmt.2016.109",

language = "English",

volume = "51",

pages = "1265--1267",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

number = "9",

}

Dourthe, ME, Ternès, N, Gajda, D, Paci, A, Dufour, C, Benhamou, E & Valteau-Couanet, D 2016, 'Busulfan-Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: An exposed-unexposed study evaluating the clinical impact of the order of drug administration', Bone Marrow Transplantation, VOL. 51, Numéro 9, p. 1265-1267. https://doi.org/10.1038/bmt.2016.109

Busulfan-Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: An exposed-unexposed study evaluating the clinical impact of the order of drug administration. / Dourthe, M. E.; Ternès, N.; Gajda, D. et al.
Dans: Bone Marrow Transplantation, Vol 51, Numéro 9, 01.09.2016, p. 1265-1267.

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

TY - JOUR

T1 - Busulfan-Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma

T2 - An exposed-unexposed study evaluating the clinical impact of the order of drug administration

AU - Dourthe, M. E.

AU - Ternès, N.

AU - Gajda, D.

AU - Paci, A.

AU - Dufour, C.

AU - Benhamou, E.

AU - Valteau-Couanet, D.

PY - 2016/9/1

Y1 - 2016/9/1

UR - http://www.scopus.com/inward/record.url?scp=84964290780&partnerID=8YFLogxK

U2 - 10.1038/bmt.2016.109

DO - 10.1038/bmt.2016.109

M3 - Letter

C2 - 27111042

AN - SCOPUS:84964290780

SN - 0268-3369

VL - 51

SP - 1265

EP - 1267

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 9

ER -

Dourthe ME, Ternès N, Gajda D, Paci A, Dufour C, Benhamou E et al. Busulfan-Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: An exposed-unexposed study evaluating the clinical impact of the order of drug administration. Bone Marrow Transplantation. 2016 sept. 1;51(9):1265-1267. doi: 10.1038/bmt.2016.109